Background: Whether the genetic influences are distinct for generalized and localization-related epilepsies or whether some susceptibility genes raise the risk for both types of epilepsy is uncertain.
T
HE RISK of epilepsy generally has been found to be higher in the relatives of probands with generalized epilepsy than in the relatives of probands with localizationrelated epilepsy. 1 Two alternative genetic models can be proposed to explain this observation. The first model assumes that the genetic influences on risk are different for generalized and localization-related epilepsies. This model predicts that relatives of probands with specific types of epilepsy will have increased risk only for the same types of epilepsy as in the probands. The second model assumes that the genetic influences on risk are the same for both types of epilepsy, but a higher genetic susceptibility is required to cause generalized epilepsy than localizationrelated epilepsy. This model predicts that risk for both types of epilepsy will be higher in the relatives of probands with generalized epilepsy than in the relatives of probands with localization-related epilepsy.
Few data are available to distinguish between these alternative models. Several recent studies suggest that there is a tendency for clinical characteristics to cluster within families. Berkovic et al 2 studied the syndrome classifications of 9 monozygotic twin pairs concordant for epilepsy and found that in every case, the syndrome classifications were concordant also. Tsuboi 3 and Beck-Mannagetta and Janz 4 found that the distribution of epilepsy types in affected relatives was skewed toward the same types of epilepsy as in the probands, although different types of epilepsy also were observed. In a study of 72 families of probands with idiopathic generalized epilepsy (IGE) syndromes, each of which contained 3 or more affected persons, multiple different IGE syndromes were observed in 54 families (75%), but few cases of localization-related epilepsy were found.
In this study, we used an epidemiologic approach to test these 2 alternative models. We compared probands with generalized and localization-related epilepsies for the risks of specific types of epilepsy in their relatives. We used the results to answer 3 specific questions. First, which type of epilepsy in the proband is associated with the highest risk of epilepsy in relatives? Second, among the relatives of probands with generalized or localization-related epilepsies, is the risk increased for epilepsy generally or only for the same type of epilepsy as in the proband? Third, is the effect of the proband's type of epilepsy the same in different classes of relatives (ie, parents, siblings, and offspring)?
RESULTS
Among the 1957 probands in the EFSCU study population, 1560 had idiopathic or cryptogenic epilepsy. Sixtytwo of the families of probands with idiopathic or cryptogenic epilepsy (4.0%) were excluded because the proband had both generalized onset and partial onset seizures (n=20) or unclassifiable epilepsy (n=42). The families of the remaining 1498 probands (generalized epilepsy, 203 [13.6%]; localization-related epilepsy, 1295
[86.4%]) included 6551 first-degree relatives who were born after 1920 (parents, 1656; siblings, 3547; offspring, 1348). We excluded 275 (4.2%) of these relatives from the study because their histories of epilepsy were unknown, leaving 6276 relatives for the present analysis. Overall, 181 (2.9%) of these relatives were classified as having idiopathic or cryptogenic epilepsy. Epilepsy was generalized in 31 (17.1%), localizationrelated in 102 (56.4%), and unclassifiable in the remaining 48 (26.5%) of the affected relatives. The proportion of affected relatives with unclassifiable epilepsy was similar in relatives of probands with generalized (25.0%) and localization-related epilepsy (26.8%).
The comparison group comprised the families of 362 EFSCU probands who had postnatal symptomatic epilepsy. These families included 1592 first-degree relatives born after 1920 (parents, 362; siblings, 887; offspring, 343), of whom 80 (5.0%) were excluded from the study because of missing information about epilepsy, leaving 1512 for the present analysis. Fifteen (1.0%) of these relatives were affected with idiopathic or cryptogenic epilepsy (generalized epilepsy, 4 
SUBJECTS AND METHODS

STUDY POPULATION
The study population comprised families of probands with epilepsy from the Epilepsy Family Study of Columbia University (EFSCU). The methods for data collection in this study have been described in detail. 6 Briefly, 1957 adults (Ն18 years old) with epilepsy (probands) were ascertained from voluntary organizations with 84% participation. We used semistructured telephone interviews to obtain detailed information on the seizure histories of the probands and their parents, full siblings, half-siblings, offspring, and spouses. Whenever possible (67% of families), we also interviewed an additional family informant (usually the mother of the proband) about the same relatives described by the proband, to improve the sensitivity of the family history data. To confirm and augment the clinical detail on the family histories, we also were able to interview 51% of living adult relatives who were reported to have had seizures when they were at least 5 years old. We obtained medical records for 60% of the probands.
Of the probands, 87% were white, 55% had at least 1 year of college education, and 60% were women. Subjects interviewed did not differ in sex or ethnicity from those who refused to be interviewed, but they were more educated. Probands ranged in age from 18 to 82 years (mean, 36 years).
CLINICAL DIAGNOSIS AND CLASSIFICATION
Probands were interviewed about the clinical symptomatology of seizures and potential causative factors for themselves and any other relative they described as having had seizures. The interviews with other family informants included the same questions about seizure type and etiology in the proband, the relative who was being interviewed, and any other relatives described by the second informant as having had seizures. Diagnoses of seizure disorders were based on a consensus review of all information collected on each proband or relative (ie, from the proband interview, the second informant interview, a direct interview, and/or the medical record). Relevant information from electroencepahlograms and magnetic resonance imaging or computed tomographic scans was seldom available; hence, the diagnosis was based solely on historical information in most cases. For each subject (proband or relative), the consensus review was performed without knowledge of the information collected on other relatives. This ensured that the diagnosis and classification of epilepsy for each subject was made independently and eliminated the potential for bias in the classification of seizures.
Epilepsy was defined as a lifetime history of at least 2 unprovoked seizures. 7 All 1957 probands were confirmed to have epilepsy in the consensus review. The proband's family history report of epilepsy in parents and siblings had excellent validity (sensitivity, 87%; specificity, 99%), using the mother's report as the "gold standard."
The proportions of relatives who were affected were similar in parents and siblings but differed in offspring ( Table 1) . Among the parents and siblings, prevalence of a history of idiopathic or cryptogenic epilepsy was higher if the proband had generalized epilepsy than if the proband had localization-related epilepsy (4.3% vs 2.2%). The RR was 4.7 for parents and siblings of probands with generalized epilepsy and 2.4 for parents and siblings of probands with localization-related epilepsy. This pattern was reversed in offspring, with a lower proportion affected if the proband's epilepsy was generalized than if it was localization-related (1.7% vs 4.8%). The RRs were 1.6 for offspring of probands with generalized epilepsy and 4.2 for offspring of probands with localizationrelated epilepsy.
Because the risks were so similar in parents and siblings, we combined them in the analyses of risks of specific types of epilepsy in relatives ( Table 2) . Regardless of the type of epilepsy in the proband, a higher proportion of the relatives had localizationrelated than generalized epilepsy. For relatives of each group of probands, the RRs in parents and siblings were similar for generalized and localization-related epilepsies (relatives of probands with generalized epilepsy, 4.8 vs 4.1; relatives of probands with localizationrelated epilepsy, 1.8 vs 2.1).
Among the offspring of probands with generalized epilepsy, only 3 were affected, and in all 3, the type of epilepsy was unknown. Among the offspring of probands with localization-related epilepsy, the RR was greater for localization-related epilepsy (7.8) than for generalized epilepsy (1.8).
We also studied the effect on our RR estimates of excluding, from the analysis of risks of specific types of epilepsy, relatives whose epilepsies could not be classified. The proportion of relatives whose epilepsies were unclassified increased from 16% (6/38) in the parents to 25% (24/97) in the siblings and 33% (20/61) in the offspring. This was unexpected, so we rereviewed the data used for epilepsy classification in all of the relatives with unclassified epilepsy. In the parents and siblings, most of the relatives with unclassified epilepsy had reported having only tonic-clonic seizures, without preictal or postictal localizing symptoms. Many of the relatives clearly should have been classified as having generalized epilepsy. In contrast, most of the offspring whose epilepsy was unclassified experienced seizure onset during childhood and had experienced remission epilepsy. Whenever a history of one of these factors was reported, we inquired about the age at which it occurred, whether seizures had occurred in close temporal association with the event, and how long after the event the seizures had occurred. Seizures occurring within 1 week after the event were classified as acute symptomatic rather than unprovoked. Although subjects who had had only acute symptomatic seizures were ineligible to be probands, some of the relatives included in the study had had only acute symptomatic seizures. We used 3 categories of causes of epilepsy: (1) idiopathic or cryptogenic, ie, epilepsy occurring in the absence of a historical insult to the central nervous system demonstrated to increase greatly the risk of unprovoked seizures; (2) neurologic deficit presumed present at birth (neurodeficit from birth), ie, epilepsy associated with a history of cerebral palsy (motor handicap or movement disorder) or mental retardation (IQ Ͻ70) presumed present at birth; and (3) postnatal symptomatic, ie, epilepsy associated with a history of a postnatal central nervous system insult occurring at least 7 days before the first unprovoked seizure.
The current classification of epileptic syndromes 12 reserves the term idiopathic to refer to a specific set of clinically described syndromes that are presumed to be genetic and cryptogenic to refer to syndromes that are presumed to be nongenetic, but with insufficient evidence to establish a specific cause. Few of the probands in our series had syndromes that would be classified as idiopathic in this context. Thus, although we refer to probands without identified causative factors as having idiopathic or cryptogenic epilepsy, this is primarily a study of epilepsies that would be classified as cryptogenic in the current classification.
The results of the previous analyses of this data set indicated that the genetic contributions to postnatal symptomatic epilepsy are minimal. 13, 14 Those analyses also suggested possible shared genetic influences on epilepsy and cerebral palsy, but persons with epilepsy and cerebral palsy may be a unique subgroup. For the present analysis, therefore, we assessed the degree of increased risk of idiopathic or cryptogenic epilepsy in the relatives of probands with idiopathic or cryptogenic epilepsy. We used the relatives of probands with postnatal symptomatic epilepsy, in whom genetic contributions seemed to be minimal, as an internal control group. This ensured that the methods for classification of epilepsy were the same in the various comparison groups.
STATISTICAL METHODS
We used Cox proportional hazards analysis 15 to compute rate ratios (RRs) for specific types of idiopathic or cryptogenic epilepsy in relatives, using the relatives of probands with postnatal symptomatic epilepsy as the reference group. We defined relatives as affected only if they had idiopathic or cryptogenic epilepsy. We assumed that each relative was at risk of idiopathic or cryptogenic epilepsy from birth until current age or age at death (for relatives without unprovoked seizures) or the age at which the first unprovoked seizure occurred. Thus, relatives with symptomatic epilepsy (ie, postnatal symptomatic epilepsy or epilepsy associated with neurodeficit from birth) were classified as unaffected, but their follow-up was considered to be censored at the age of their first unprovoked seizure. Similarly, in the analysis of risk of idiopathic or cryptogenic generalized or localization-related epilepsy specifically, relatives with the specific type under consideration were classified as affected, and relatives with the other type (or whose epilepsy type was unknown) were classified as unaffected, with follow-up censored at the age of their first unprovoked seizure. Relatives whose histories of epilepsy were unknown were excluded from the study.
In a previous analysis of this data set, we found that epilepsy was underreported in older relatives. 16 The greatest underreporting was for relatives born in 1920 or earlier; thus, the present analysis was restricted to relatives born after 1920. soon after onset, or they were still too young for a detailed description of symptoms to be obtained. Many of the offspring with unclassified epilepsy also probably had generalized epilepsy. Childhood onset epilepsies with early remission were probably underreported in parents and siblings and may account for the higher proportion of offspring with epilepsy that could not be classified.
Because a disproportionate number of the relatives with unclassified epilepsy probably had generalized epilepsy, we repeated the analysis in Table 2 , assuming that epilepsy was generalized in all relatives with unclassified epilepsy. The RRs for generalized epilepsy rose to 5.8 for parents and siblings of probands with generalized epilepsy, 3.0 for parents and siblings of probands with localization-related epilepsy, 3.1 for offspring of probands with generalized epilepsy, and 2.1 for offspring of probands with localizationrelated epilepsy. The RRs for localization-related epilepsy remained the same as in Table 2 .
COMMENT
These results are inconsistent with a model of distinct genetic influences on generalized and localizationrelated epilepsies. Such a model would predict that in the relatives of probands with generalized epilepsies, the risk of localization-related epilepsy is not increased, ie, RR of 1.0. However, our data indicate that risk is increased for both generalized (RR, 4.8) and localization-related epilepsy (RR, 4.1) in the parents and siblings of probands with generalized epilepsy. Our results for the parents and siblings of probands with localization-related epilepsy also are inconsistent with a model of specificity in the genetic effects. Such a model would predict an RR of 1.0 for generalized epilepsy in the relatives of probands with localization-related epilepsy. We found instead that in the parents and siblings of probands with localization-related epilepsy, the risk was increased for both generalized (RR, 1.8) and localization-related 
T HESE FINDINGS are different from those of several other investigations, [2] [3] [4] [5] which have suggested that epilepsy types tend to be similar in affected family members. Part of this difference may be explained by a difference in methods. In our study, epilepsy in each proband or relative was classified without knowledge of the number of affected persons in the family and the epilepsy classifications in other family members. None of the previous study reports stated that this was done. The different results in other studies may also be explained by a different distribution of epilepsy types in the probands. Most of the previous studies focused on probands with IGE syndromes, whereas our study population contained few probands with IGE syndromes. The low proportion of probands with IGE syndromes in our study is a consequence of our ascertainment protocol, which involved sampling adults with epilepsy from voluntary organizations. Many IGEs have onset in childhood or adolescence and tend to remit before adulthood. Hence, among the adult probands with idiopathic or cryptogenic epilepsy in our study, only 14% had generalized epilepsies, and these generalized epilepsies were unusual because they either had late onset or long duration. Because of this selection bias, our results do not apply to the genetics of IGE syndromes. Unlike the genetic influences on other forms of idiopathic or cryptogenic epilepsy, the genetic influences on IGE syndromes may be specific for IGE syndromes (although they may be shared across different forms of IGE syndromes [juvenile myoclonic epilepsy, childhood absence epilepsy, etc]).
In a previous analysis of data from the RochesterOlmsted County, Minnesota, record linkage project, 17 the risks of unprovoked seizures were similar for the offspring of probands with generalized and localizationrelated epilepsies overall, but the risks in the offspring were higher for the subset of probands with absence seizures. Furthermore, in the offspring of probands with absence seizures, the degree of increased risk was greater for absence than for other seizure types. In the present study, risks were not higher in the relatives of probands with absence seizures than in the relatives of probands with generalized epilepsy without absence seizures (proportion affected among relatives of probands with absence seizures: offspring, 0/71 [0%]; parents and siblings, 11/273 [4.0%]). As noted, the different findings in our present study might be attributed to a different distribution of epilepsy types (eg, as defined by age at onset or duration of illness), among the probands with absence seizures in our study.
One of the most intriguing findings of the present study is that the patterns of familial risk are different in offspring than in parents and siblings. In the parents and siblings, risk is higher if the proband had generalized epilepsy, whereas in the offspring, risk is higher if the proband had localization-related epilepsy. Furthermore, the increased risk in the offspring of probands with localization-related epilepsy is greater for localizationrelated than for generalized epilepsy. This is true even if all of the offspring whose epilepsy could not be classified are assumed to have generalized epilepsy.
The validity of our results hinges on the validity of the classification of seizure type in probands and affected relatives. Although our seizure classifications had adequate validity when compared with diagnoses of physicians who used the same criteria for classification, 11 errors in classification were almost always in the direction of misclassifying truly generalized seizures as partial onset (sensitivity and specificity for generalized onset seizures, 60% and 100%; for partial onset seizures, 100% and 75%, respectively). Thus, the classifications for most of the probands and relatives classified as having generalized epilepsy were probably correct, whereas some of those classified as having localization-related epilepsy probably actually had generalized epilepsy.
This type of misclassification would be expected to have 2 effects on the RRs estimated in this study. First, misclassification of epilepsy in the probands would inflate the estimate of the RR for generalized epilepsy in the relatives of probands with localization-related epilepsy. This is expected because a proportion of the probands classified as having localization-related epilepsy actually had generalized epilepsy, and familial risk is greater for those with generalized epilepsy than for those with localization-related epilepsy. Second, misclassification of epilepsy in the relatives would inflate the estimate of the RR for localization-related epilepsy in the relatives of probands with generalized epilepsy. This is expected because a proportion of the relatives classified as having localization-related epilepsy actually had generalized epilepsy. No bias is expected in the RR of generalized epilepsy in the relatives of probands with generalized epilepsy because few of the probands or relatives in that analysis had epilepsy that was misclassified.
We evaluated the magnitude of the bias in our RR estimates due to misclassification by developing a statistical model with the following assumptions: (1) the risk of all idiopathic or cryptogenic epilepsy in relatives was 4% for probands with generalized idiopathic or cryptogenic epilepsy, 2% for probands with localizationrelated idiopathic or cryptogenic epilepsy, and 1% for control probands (based on the results in Table 1 for parents and siblings); and (2) among the affected relatives of control probands, 50% had localization-related and 50% had generalized epilepsy (based on the distribution of incident idiopathic or cryptogenic epilepsy in Rochester, Minn [W.A.H., unpublished data, 1997]). We then evaluated the effects on the RRs estimated in Table 2 of varying degrees of misclassification of epilepsy in the probands and relatives.
Although our observed RR of 4.1 for localizationrelated epilepsy in the parents and siblings of probands with generalized epilepsy (Table 2) is inflated because of misclassification, the true RR is unlikely to be as low as 1.0. Under the assumptions described in the previous paragraph, if the RR for generalized epilepsy in the relatives of probands with generalized epilepsy is 5.0 (based on our estimate of 4.8 in parents and siblings from Table  2 , which should be unbiased), then the true RR (with no misclassification) for localization-related epilepsy in the relatives of probands with generalized epilepsy would be 3.0. If the true RR for generalized epilepsy in the relatives of probands with generalized epilepsy were 5.8, as estimated from our analysis assuming that epilepsy was generalized in all of those with unclassified epilepsy, then the true RR for localization-related epilepsy in relatives of generalized probands would be 2.0. Conversely, if the true RR for localization-related epilepsy in relatives of probands with generalized epilepsy were 1.0, the observed RR would not be as high as our observed value of 4.1 unless the epilepsy in more than 90% of the relatives were misclassified, which is unlikely. Similarly, an RR of 3.0 for generalized epilepsy in the relatives of probands with localization-related epilepsy (as estimated in parents and siblings, assuming that epilepsy was generalized in all with unclassified epilepsy) would be observed only if the epilepsy in 60% to 70% of the probands with generalized epilepsy were misclassified, which is unlikely. 11 Our results indicate that some of the genetic influences on epilepsy are common to generalized and localization-related epilepsies. In the offspring of probands with localization-related epilepsy, an additional influence may raise the risk for localization-related epilepsy specifically. This difference between offspring and other relatives in the patterns of familial risk is unexplained and should be investigated further.
